Raymond N. Habbaz

Raymond N. Habbaz — Patent Litigation Practice Summary

Raymond Habbaz is an Associate in the New York office of Desmarais LLP, a boutique IP litigation firm, where he has spent his entire post-law-school career (joining after his 2018 NYU Law graduation). Per his firm bio, his practice covers patent, appellate, and PTAB litigation across medical devices and diagnostics, consumer electronics, telecommunications, and computer software — a technology mix consistent with his undergraduate chemistry degree. His docket spans district court, Federal Circuit, and ITC matters.

On the tracked case list, Habbaz's sole appearance is defendant-side: Biofrontera Pharma GmbH v. Sun Pharmaceutical Industries Inc. Notably, he was on the Desmarais team that secured a complete ITC victory for Sun in the parallel Section 337 investigation (Inv. No. 337-TA-1411), winning a final determination that Biofrontera's RhodoLED XL photodynamic-therapy system infringed Sun's patents, with limited exclusion and cease-and-desist orders. His broader docket, however, is mixed: he has served as defense counsel for Intel (summary judgment of noninfringement in XMTT v. Intel, affirmed by the Federal Circuit in December 2024) and Apple, while also working plaintiff-side for IBM (a $44.9M jury verdict against Zynga in Delaware, September 2024), Avanos Medical against Medtronic, and Sun in the underlying Biofrontera dispute. The tracked data's 0:1 plaintiff/defendant split thus understates a practice that regularly works both sides.

Habbaz has genuine PTAB exposure but is not a PTAB specialist: his firm bio identifies IPR/PGR work as part of his practice, and he was on the Avanos team that won an IPR upholding all challenged claims. In the Sun/Biofrontera matter, the parallel IPR on the '028 patent (IPR2024-01312) initially went against Sun at the Board, but the USPTO Director vacated that decision in July 2026 and dismissed the petition — a notable favorable development for his client. He is admitted in New York (2019) and before the Federal Circuit and the Southern District of New York; his prior experience is limited to a 2017 summer associateship at Paul, Weiss.